之江生物：战略增持三优生物，深化“诊断+治疗”全产业链布局

Core Viewpoint - Zhijiang Biotech has completed a strategic increase in its stake in Sanyou Biopharmaceutical Co., Ltd., emphasizing the importance of technological complementarity and industrial synergy in the biopharmaceutical sector [1] Group 1: Company Actions - The strategic increase in stake aims to further integrate advantageous resources and solidify Zhijiang Biotech's position in the full industry chain of precision medicine, focusing on "diagnosis + treatment" [1] - The financing round also attracted interest from Shenzhen Yanghe Investment Pharmaceutical Industry Investment Co., Ltd., a professional investment platform under Zhuhai Gree Group, which participated in the strategic investment in Sanyou Biopharmaceutical [1]